These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20850487)

  • 1. Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays.
    Chen X; Kask AS; Crichton ML; McNeilly C; Yukiko S; Dong L; Marshak JO; Jarrahian C; Fernando GJ; Chen D; Koelle DM; Kendall MA
    J Control Release; 2010 Dec; 148(3):327-33. PubMed ID: 20850487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge.
    Kask AS; Chen X; Marshak JO; Dong L; Saracino M; Chen D; Jarrahian C; Kendall MA; Koelle DM
    Vaccine; 2010 Nov; 28(47):7483-91. PubMed ID: 20851091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8(+) T cell responses.
    Fernando GJ; Zhang J; Ng HI; Haigh OL; Yukiko SR; Kendall MA
    J Control Release; 2016 Sep; 237():35-41. PubMed ID: 27381247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intramuscular and footpad subcutaneous immunization with DNA vaccine encoding HSV-gD2 in mice.
    Jazayeri M; Soleimanjahi H; Fotouhi F; Pakravan N
    Comp Immunol Microbiol Infect Dis; 2009 Sep; 32(5):453-61. PubMed ID: 18571235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization.
    Chen X; Fernando GJ; Crichton ML; Flaim C; Yukiko SR; Fairmaid EJ; Corbett HJ; Primiero CA; Ansaldo AB; Frazer IH; Brown LE; Kendall MA
    J Control Release; 2011 Jun; 152(3):349-55. PubMed ID: 21371510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice.
    Prow TW; Chen X; Prow NA; Fernando GJ; Tan CS; Raphael AP; Chang D; Ruutu MP; Jenkins DW; Pyke A; Crichton ML; Raphaelli K; Goh LY; Frazer IH; Roberts MS; Gardner J; Khromykh AA; Suhrbier A; Hall RA; Kendall MA
    Small; 2010 Aug; 6(16):1776-84. PubMed ID: 20665754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid kinetics to peak serum antibodies is achieved following influenza vaccination by dry-coated densely packed microprojections to skin.
    Chen X; Fernando GJ; Raphael AP; Yukiko SR; Fairmaid EJ; Primiero CA; Frazer IH; Brown LE; Kendall MA
    J Control Release; 2012 Feb; 158(1):78-84. PubMed ID: 22063004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin.
    Chen X; Prow TW; Crichton ML; Jenkins DW; Roberts MS; Frazer IH; Fernando GJ; Kendall MA
    J Control Release; 2009 Nov; 139(3):212-20. PubMed ID: 19577597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal delivery of protein and DNA vaccines.
    Dean HJ
    Expert Opin Drug Deliv; 2005 Mar; 2(2):227-36. PubMed ID: 16296750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL1 gene silencing in skin using liposome-encapsulated siRNA delivered by microprojection array.
    Haigh O; Depelsenaire AC; Meliga SC; Yukiko SR; McMillan NA; Frazer IH; Kendall MA
    J Control Release; 2014 Nov; 194():148-56. PubMed ID: 25192942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LFA-3 plasmid DNA enhances Ag-specific humoral- and cellular-mediated protective immunity against herpes simplex virus-2 in vivo: involvement of CD4+ T cells in protection.
    Sin JI; Kim J; Dang K; Lee D; Pachuk C; Satishchandran C; Weiner DB
    Cell Immunol; 2000 Jul; 203(1):19-28. PubMed ID: 10915558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of potent CD8⁺ T cell responses through the delivery of subunit protein vaccines to skin antigen-presenting cells using densely packed microprojection arrays.
    Ng HI; Fernando GJ; Kendall MA
    J Control Release; 2012 Sep; 162(3):477-84. PubMed ID: 22841796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.
    Fotouhi F; Soleimanjahi H; Roostaee MH; Behzadian F
    FEMS Immunol Med Microbiol; 2008 Oct; 54(1):18-26. PubMed ID: 18647350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis.
    Dean HJ; Fuller D; Osorio JE
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):373-88. PubMed ID: 12818623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of strain rate on the precision of penetration of short densely-packed microprojection array patches coated with vaccine.
    Crichton ML; Ansaldo A; Chen X; Prow TW; Fernando GJ; Kendall MA
    Biomaterials; 2010 Jun; 31(16):4562-72. PubMed ID: 20226519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.
    Bourne N; Bravo FJ; Francotte M; Bernstein DI; Myers MG; Slaoui M; Stanberry LR
    J Infect Dis; 2003 Feb; 187(4):542-9. PubMed ID: 12599070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted, needle-free vaccinations in skin using multilayered, densely-packed dissolving microprojection arrays.
    Raphael AP; Prow TW; Crichton ML; Chen X; Fernando GJ; Kendall MA
    Small; 2010 Aug; 6(16):1785-93. PubMed ID: 20665628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine.
    Kohl S; Charlebois ED; Sigouroudinia M; Goldbeck C; Hartog K; Sekulovich RE; Langenberg AG; Burke RL
    J Infect Dis; 2000 Jan; 181(1):335-9. PubMed ID: 10608784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
    Wizel B; Persson J; Thörn K; Nagy E; Harandi AM
    Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-encoded b7-2 costimulation molecules enhance the protective capacity of a replication-defective herpes simplex virus type 2 vaccine in immunocompetent mice.
    Vagvala SP; Thebeau LG; Wilson SR; Morrison LA
    J Virol; 2009 Jan; 83(2):953-60. PubMed ID: 18987142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.